Meta-analysis results for all treatments

Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). method

Treament Trials
Summary Endpoints
     
clinical deteriorationclinical improvementdeathsPCR-negative conversion
chloroquine and derivatives5- 8.18 [0.32; 209.71], 3 RCTs, I2=82%
inconclusive result		--
ASC09/ritonavir0----
azithromycin0----
azvudine0----
baloxavir marboxil0----
carrimycin0----
danoprevir / ritonavir0----
darunavir cobicistat0----
darunavir/cobicistat plus chloroquine0----
doxycycline0----
favipiravir 0----
fluvoxamine0----
hydroxychloroquine plus macrolides0----
ivermectin0----
leronlimab0----
lopinavir / ritonavir plus ribavirin0----
lopinavir/ritonavir0----
lopinavir/ritonavir plus chloroquine0----
lopinavir/ritonavir plus interferon ß-1a0----
lopinavir/ritonavir, ribavirin and interferon beta-1b0----
meplazumab0----
nitazoxanide0----
oseltamivir0----
oseltamivir plus chloroquin0----
remdesivir0----
Renin-angiotensin-system-acting agents0----
ribavirin0----
ritonavir0----
sofosbuvir and daclatasvir0----
tenofovir/emtricitabine0----
tenofovir/emtricitabine plus hydroxychloroquine0----
tranexamic acid0----
triazavirin0----
umifenovir (arbidol)0----

- About us - Contact us - Method Made with in Lyon - Credits - Privacy policy - Licence Creative Commons